| __timestamp | Agios Pharmaceuticals, Inc. | Viatris Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 19120000 | 1499100000 |
| Thursday, January 1, 2015 | 35992000 | 1923500000 |
| Friday, January 1, 2016 | 50714000 | 2351400000 |
| Sunday, January 1, 2017 | 71124000 | 2564000000 |
| Monday, January 1, 2018 | 114145000 | 2397300000 |
| Tuesday, January 1, 2019 | 132034000 | 2503400000 |
| Wednesday, January 1, 2020 | 149070000 | 3344600000 |
| Friday, January 1, 2021 | 121445000 | 4529200000 |
| Saturday, January 1, 2022 | 121673000 | 4179100000 |
| Sunday, January 1, 2023 | 119903000 | 4650100000 |
| Monday, January 1, 2024 | 156784000 |
Igniting the spark of knowledge
In the ever-evolving pharmaceutical industry, understanding the financial dynamics of companies is crucial. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of Viatris Inc. and Agios Pharmaceuticals, Inc. over the past decade.
Viatris Inc. has shown a consistent increase in SG&A expenses, peaking in 2023 with a staggering 210% rise from 2014. This growth reflects the company's expansive strategies and market penetration efforts.
In contrast, Agios Pharmaceuticals, Inc. experienced a more modest increase, with expenses growing by approximately 525% over the same period. This indicates a more conservative approach, focusing on sustainable growth.
These trends highlight the differing strategies of these companies, offering insights into their operational priorities and market strategies.
SG&A Efficiency Analysis: Comparing Johnson & Johnson and Viatris Inc.
Who Optimizes SG&A Costs Better? Gilead Sciences, Inc. or Viatris Inc.
SG&A Efficiency Analysis: Comparing Viatris Inc. and Blueprint Medicines Corporation
Who Optimizes SG&A Costs Better? Viatris Inc. or CymaBay Therapeutics, Inc.
Cost Insights: Breaking Down Viatris Inc. and Agios Pharmaceuticals, Inc.'s Expenses
Comparing SG&A Expenses: Viatris Inc. vs ACADIA Pharmaceuticals Inc. Trends and Insights
Comparing SG&A Expenses: Viatris Inc. vs Soleno Therapeutics, Inc. Trends and Insights
Selling, General, and Administrative Costs: Viatris Inc. vs Veracyte, Inc.
Operational Costs Compared: SG&A Analysis of Viatris Inc. and Galapagos NV
Selling, General, and Administrative Costs: Alpine Immune Sciences, Inc. vs Agios Pharmaceuticals, Inc.
Comparing SG&A Expenses: Bausch Health Companies Inc. vs Agios Pharmaceuticals, Inc. Trends and Insights
Selling, General, and Administrative Costs: Arrowhead Pharmaceuticals, Inc. vs Agios Pharmaceuticals, Inc.